Voloridge Investment Management
WVE icon

Voloridge Investment Management’s Wave Life Sciences WVE Stock Holding History

Voloridge Investment Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-288,502
Closed -$2.09M – 1114
2026
Q1 		$2.09M Sell
288,502
-433,735
-60% -$5.65M 0.01% 823
2025
Q4 		$12.3M Buy
+722,237
New +$7.34M 0.04% 521
2025
Q3 		– Sell
-683,193
Closed -$4.44M – 1424
2025
Q2 		$4.44M Sell
683,193
-87,514
-11% -$578K 0.02% 782
2025
Q1 		$6.23M Sell
770,707
-75,123
-9% -$822K 0.02% 723
2024
Q4 		$10.5M Buy
+845,830
New +$11.3M 0.04% 560
2021
Q2 		– Sell
-14,053
Closed -$79K – 1813
2021
Q1 		$79K Sell
14,053
-125,038
-90% -$1.2M ﹤0.01% 1346
2020
Q4 		$1.09M Sell
139,091
-252,098
-64% -$2.12M 0.01% 943
2020
Q3 		$3.32M Buy
391,189
+353,128
+928% +$3.87M 0.03% 559
2020
Q2 		$396K Sell
38,061
-9,949
-21% -$93.6K ﹤0.01% 1078
2020
Q1 		$450K Buy
+48,010
New +$409K 0.01% 741
2019
Q4 		– Sell
-12,899
Closed -$265K – 1375
2019
Q3 		$265K Sell
12,899
-9,517
-42% -$218K ﹤0.01% 953
2019
Q2 		$585K Buy
+22,416
New +$629K 0.02% 540

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Voloridge Investment Management's WVE Position: Q2 2026 in Review

Voloridge Investment Management sold out of Wave Life Sciences (WVE) in Q2 2026, closing a stake of 288,502 shares — an estimated $2.09M sold.

Voloridge Investment Management first reported a position in WVE in Q2 2019 and held it in 12 quarters. The position peaked at $12.3M in Q4 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Voloridge Investment Management reported no remaining Wave Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Voloridge Investment Management sold 288,502 Wave Life Sciences shares in Q2 2026, an estimated $2.09M.
  • Voloridge Investment Management first reported a position in Wave Life Sciences in Q2 2019 and held it in 12 quarters.
  • Voloridge Investment Management's Wave Life Sciences position peaked at $12.3M in Q4 2025.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Voloridge Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.